<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02180425</url>
  </required_header>
  <id_info>
    <org_study_id>531506</org_study_id>
    <nct_id>NCT02180425</nct_id>
  </id_info>
  <brief_title>The Lipid Profile of the Skin Surface in Acne</brief_title>
  <acronym>Acne</acronym>
  <official_title>The Lipid Profile of the Skin Surface in Acne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the differences in the skin lipid profile of
      patients with and without acne. Secondly, the goal is to learn more about what the effects of
      retinoinds (topical and systemic) are on the the skin lipid profile. We hypothesize that the
      skin lipid profile of subjects with acne will be lower in inflammatory lipids in comparison
      to subjects without acne.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Skin lipid profile will be conducted via sebutapes- adhesive tapes that painlessly absorbs
      sebum from the face. These tapes will be placed on the face for 1 hour. A photograph of the
      face will be taken during each study visit. A sebumeter will also be used to measure skin
      sebum secretion rate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skin lipid profile of acne and healthy patients</measure>
    <time_frame>baseline visit</time_frame>
    <description>Compare the skin lipid profile of acne and healthy patients at baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin lipid profile of acne patients after treatment</measure>
    <time_frame>at 1 month and 4-5 months of treatment</time_frame>
    <description>Patients in the topical retinoid group will have their lipids evaluated after 1 month of treatment. Patients in the systemic retinoid (isotretinoin) group will have their lipids evaluated after 1 and 4-5 months of treatment.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Acne</condition>
  <arm_group>
    <arm_group_label>Healthy Group</arm_group_label>
    <description>The subjects in this group do not have a history of acne.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acne Group, Topical Retinoid</arm_group_label>
    <description>These subjects have been prescribed a topical retinoid for their acne. They will participate in the study for a period of 1 month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acne Group, Isotretinoin</arm_group_label>
    <description>These subjects have been prescribed isotretinoin for their acne. They will participate in the study for a period of 5-6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tretinoin or Adapalene</intervention_name>
    <description>Subjects will apply a pea sized amount of topical retinoid cream once daily at night for 30 days. Subjects will return for a follow-up visit.</description>
    <arm_group_label>Acne Group, Topical Retinoid</arm_group_label>
    <other_name>Retin A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotretinoin</intervention_name>
    <description>Subjects will take one pill once daily for 5 months. Subjects will return after 1 month and after 4-5 months of treatment for skin lipid profiling.</description>
    <arm_group_label>Acne Group, Isotretinoin</arm_group_label>
    <other_name>Accutane</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sebum collections from sebutapes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be from the UC Davis Dermatology Clinic, surrounding dermatology clinics,
        from the UC Davis undergraduate campus, and from the California State University Sacramento
        campus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 12 to 30 years

          -  have been prescribed tretinoin OR isotretinoin

        Exclusion Criteria:

          -  those who have taken isotretinoin (systemic)

          -  those who used tretinoin or other topical retinoid within two weeks of starting the
             study

          -  those with seborrheic dermatitis, rosacea, or polycystic ovary syndrome

          -  those who are pregnant, prisoners, or cognitively impaired

          -  those who do not fit the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raja K Sivamani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Research Area</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Department of Dermatology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ucdmc.ucdavis.edu/dermatology/research/clinical</url>
    <description>University of California-Davis Department of Dermatology Clinical Research</description>
  </link>
  <reference>
    <citation>Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989 Apr;69(2):383-416. Review.</citation>
    <PMID>2648418</PMID>
  </reference>
  <reference>
    <citation>Blume U, Verschoore M, Poncet M, Czernielewski J, Orfanos CE, Schaefer H. The vellus hair follicle in acne: hair growth and sebum excretion. Br J Dermatol. 1993 Jul;129(1):23-7.</citation>
    <PMID>8369207</PMID>
  </reference>
  <reference>
    <citation>Zouboulis CC, Baron JM, BÃ¶hm M, Kippenberger S, Kurzen H, Reichrath J, Thielitz A. Frontiers in sebaceous gland biology and pathology. Exp Dermatol. 2008 Jun;17(6):542-51. doi: 10.1111/j.1600-0625.2008.00725.x. Review.</citation>
    <PMID>18474083</PMID>
  </reference>
  <reference>
    <citation>Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997 Jun;36(6):416-8.</citation>
    <PMID>9248884</PMID>
  </reference>
  <reference>
    <citation>Morello AM, Downing DT, Strauss JS. Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol. 1976 May;66(5):319-23.</citation>
    <PMID>131844</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2014</study_first_submitted>
  <study_first_submitted_qc>June 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2014</study_first_posted>
  <last_update_submitted>May 25, 2017</last_update_submitted>
  <last_update_submitted_qc>May 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acne</keyword>
  <keyword>lipid</keyword>
  <keyword>tretinoin</keyword>
  <keyword>isotretinoin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tretinoin</mesh_term>
    <mesh_term>Isotretinoin</mesh_term>
    <mesh_term>Adapalene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

